A recently published report titled, “3D Cell Culture Market: Opportunity Analysis and Future Assessment 2022-2030” offers a thorough and profound assessment of the market stature along with the top leading facts and figures, definition, overview, expert opinions, SWOT analysis, as well as the recent developments of the market all around the world. The market report also computes the market size, market sales, revenue, price, market share, gross margin and market forecast, growth rate, and cost structure. The report estimates the revenue created from the sales and technologies by various application segments.
The 3D cell culture market is estimated to reach at a value of US$ 1.8 Bn by the end of 2022 and expected to reach at a value of US$ 3.7 Bn by 2030 with a significant CAGR of 9.6%.
Request To Download Sample of 3D Cell Culture Market Report:
Reports & Insights Overview
3D cell culture can be perceived as a cultural environment that enables cells to develop and communicate with encompassing extracellular structures in three dimensions. This is compared to the conventional 2D cell cultures in which cells are matured in a flat monolayer on a plate. 3D cell cultures can be developed and matured with or without a backing scaffold. Cell culture techniques are pervasive in domains of drug discovery, developmental biology, protein production, and regenerative medicine. Considering the advent of cell culture approaches, cells have been cultured in two dimensions, affiliated to ECM attachment proteins or tissue culture plasticware. Cells in the physiological environment have perpetual communication with the extracellular matrix, governing intricate biological functions like apoptosis, cellular migration, receptor expression, and transcriptional regulation.
However, in-vitro experimental data cannot be rendered into clinical trials entirely when cells are matured in 2D conditions since intricate cellular signals between cells and their matrix cannot be duplicated. Nevertheless, the three-dimensional cell cultures tackle this issue and serve as an improved model depicting in vivo physiological conditions precisely. Owing to this, the 3D cell culture is gaining momentum all across the healthcare sector, thereby the global 3D cell culture market is projected to witness significant growth over the following years.
3D Cell Culture Market Segmentation
The global 3D Cell Culture market is segmented on the basis of product type, application, end-user, and region.
By Product Type
Scaffold-based 3D Cell Cultures
Hydrogels/ECM Analogs
Solid Scaffolds
Micropatterned Surfaces
Nanofiber-based Scaffolds
Scaffold-free 3D Cell Cultures
Low Attachment Plates
Hanging Drop Plates
3D Bioreactors
3D Petri Dishes
Microfluidics-based 3D Cell Cultures
Magnetic & Bioprinted 3D Cell Cultures
By Application
Cancer & Stem Cell Research
Drug Discovery
Toxicology Testing
Tissue Engineering
Regenerative Medicine
By End User
Pharmaceutical & Biotechnology Companies
Research Institutes
Cosmetics Industry
Other End Users
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
3D Cell Culture Market Key Players
Some of the key participating players in the global 3D Cell Culture market are:
Thermo Fisher Scientific
Corning Incorporated
Merck KGaA
Lonza AG
REPROCELL Incorporated
TissUse
InSphero
Synthecon
3D Biotek
CN Bio
Hamilton Company
MIMETAS
Emulate
Hµrel Corporation
Quel SA
SynVivo
Advanced BioMatrix
Greiner Bio-One International
PromoCell
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth include (but are not restricted to):
New product designs and launches
Current product compliance
Reimbursement
Concerns for use of 3D Cell Culture
Advantages of 3D Cell Culture
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at the regional level and in major countries globally for providing regional insights into the product segment in the report. This helps our clients to make an informed decision.
A mix of top-down and bottom-up approaches is followed to arrive at and validate our market value estimations. For a product segment wherein one/two manufacturer(s) dominates the market, its product sales, previous growth rates, and market expansion plans are considered to generate market share in the market.